In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including Medicare Part D impacts from the Inflation Reduction Act, Novo Nordisk’s cuts to insulin prices, and the PBM Transparency Act of 2023.
Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, Medicare, drug prices, PBMs
Source Links:
- True catastrophic coverage and shifting liability: Preparing for IRA changes
- Inflation Reduction Act: What health plans and Part D sponsors need to know to be prepared
- Novo Nordisk follows Eli Lilly’s lead, slashing insulin prices in the US
- Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
- Senate panel advances bill to reform PBMs and bring more FTC scrutiny on industry
- Commerce Committee Approves Cantwell, Grassley Bipartisan Bill to Combat Rising Prescription Drug Prices
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Healthcare Industry Strategist
Listen now
Speed to publication with GenAI: Done the right way
In the last three years, Generative AI (GenAI) has moved from novelty to expectation. Across industries, teams are being asked, whether explicitly or
Read moreInizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read moreASH® 2025 roundtable: Turning hematology innovation into real world progress
Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read more